AXSM icon

Axsome Therapeutics
AXSM

Upgrade to unlock
Buy
Hold
Sell

9 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$229
24% upside
High target

9 analyst ratings

positive
0  neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
UBS
UBS
Ashwani Verma
50% 1-yr AXSM win rate
24 Feb ‘26 1 month ago
Guggenheim
Guggenheim
Yatin Suneja
50% 1-yr AXSM win rate
24 Feb ‘26 1 month ago
RBC Capital
RBC Capital
Leonid Timashev
50% 1-yr AXSM win rate
24 Feb ‘26 1 month ago
Wells Fargo
Wells Fargo
Benjamin Burnett
50% 1-yr AXSM win rate
24 Feb ‘26 1 month ago
Wolfe Research
Wolfe Research
Rudy Li
0% 1-yr AXSM win rate
24 Feb ‘26 1 month ago
Needham
Needham
Ami Fadia
50% 1-yr AXSM win rate
23 Feb ‘26 1 month ago
Jefferies
Jefferies
Andrew Tsai
50% 1-yr AXSM win rate
3 Feb ‘26 2 months ago
Leerink Partners
Leerink Partners
Marc Goodman
0% 1-yr AXSM win rate
28 Jan ‘26 2 months ago
HC Wainwright & Co
HC Wainwright & Co
Raghuram Selvaraju
57% 1-yr AXSM win rate
20 Jan ‘26 2 months ago